Differential expression analysis identified 27 glycolytic hub genes, including STMN1, SOD1, and TPI1, many of which are previously implicated in CRC metabolism and therapy resistance (Shi et al., 2020; Chen et al., 2022). The gene discussed is TPI1; the disease is colorectal carcinoma.